Se espera que el mercado de terapéutica glucómica crezca de 99.021,46 millones de dólares en 2021 a 257.578,79 millones de dólares en 2028; se estima que crecerá con una tasa compuesta anual del 15,8 % de 2022 a 2028.
El informe destaca las tendencias predominantes y los factores que impulsan el crecimiento del mercado. La glucómica se centra en las estructuras y funciones de los carbohidratos complejos, como los que se encuentran en las glicoproteínas, los glicolípidos y los glicosaminoglicanos. Los glicanos son responsables de gran parte de la variación estructural en los sistemas biológicos y su representación en las superficies celulares se denomina comúnmente "glicoma". Estos glicanos están presentes en muchas áreas del microbioma, incluidas las superficies celulares y las proteínas, y pueden ser increíblemente complejos. La glucómica microbiana está preparada para revolucionar el diagnóstico de enfermedades, la detección del cáncer, la medicina personalizada, las vacunas antimicrobianas y el descubrimiento de fármacos. Como agentes terapéuticos, los nanomateriales integrados en glicano se pueden utilizar como vacuna contra infecciones virales y bacterianas y células cancerosas.
El informe ofrece información y un análisis en profundidad del mercado mundial de terapias glucómicas, haciendo hincapié en varios parámetros, incluidas las tendencias del mercado, los avances tecnológicos, la dinámica del mercado y el análisis del panorama competitivo de los principales actores del mercado mundial. También incluye el impacto de la pandemia de COVID-19 en el mercado de todas las regiones. El impacto general de la pandemia de COVID-19 en el mercado de la terapéutica glucómica fue mixto; por lo tanto, el mercado sigue ganando terreno y se espera que crezca en los próximos años. Los sistemas de atención de salud estaban sobrecargados y brindar atención médica a todos los pacientes se convirtió en un desafío. Además, la industria biotecnológica enfrentó el impacto indeseable de la pandemia. Durante la pandemia de COVID-19, las empresas de dispositivos médicos encontraron dificultades para gestionar sus operaciones. Muchas empresas de terapéutica glucómica tenían sus operaciones comerciales en Estados Unidos y la pandemia afectó gravemente a varios negocios. Sin embargo, una vez que se normalizaron las restricciones pandémicas, el volumen de procedimientos quirúrgicos volvió a niveles normales. Poco a poco, los hospitales reanudaron los procedimientos electivos a medida que aumentaba la tasa de recuperación de la COVID-19. La demanda de medicamentos a base de glucanos en aplicaciones terapéuticas médicas y desarrollo de vacunas también ha aumentado.
Información estratégica
Información geográfica
Por geografía, el mercado global El mercado de terapéutica glucómica está segmentado en América del Norte (EE. UU., Canadá y México), Europa (Reino Unido, Alemania, Francia, Italia, España y el resto de Europa), Asia Pacífico (China, Japón, India, Australia, Sur). Corea y el resto de Asia Pacífico), Oriente Medio y Asia. África (Emiratos Árabes Unidos, Arabia Saudita, Sudáfrica y el resto de Medio Oriente y África) y Sur y África. Centroamérica (Brasil, Argentina y el resto de América Central y del Sur).
Perspectivas del mercado
Aumento de la investigación y el desarrollo en el campo del glicómico Terapéutica
Los glicanos son extremadamente complejos y se encuentran en muchas áreas de los componentes del microbioma, como proteínas y superficies celulares. Los investigadores y actores participan activamente en la industria de la glucómica y se centran constantemente en los desarrollos tecnológicos para ofrecer mejores alternativas a las técnicas convencionales. Algunos ejemplos de investigación y Los avances en el mercado de la terapéutica glucómica se mencionan a continuación:
- En febrero de 2022, la Fundación Nacional de Ciencias (NSF) otorgó ~23 millones de dólares a una nueva asociación multiuniversitaria, liderada conjuntamente por Virginia Tech. y la Universidad de Georgia, 2020, para acelerar la investigación de glicomateriales en EE. UU. Esta asociación reunió a los mejores científicos e ingenieros de estas instituciones, junto con la Universidad Brandeis, el Instituto Politécnico Rensselaer y la Universidad de Carolina del Norte en Chapel Hill, para establecer un centro nacional de investigación de glicomateriales.
- En marzo de 2022, Palleon Pharmaceuticals, una empresa pionera en el campo de la inmunología del glicol para tratar el cáncer y las enfermedades inflamatorias, anunció la dosificación del primer paciente en el estudio de fase 1/2 de la empresa de E-602 en pacientes que padecen cánceres avanzados. El estudio, llamado GLIMMER-01 (Regulación inmune de glicanos), es el primer estudio clínico del novedoso enfoque de Palleon para la inmunoterapia contra el cáncer, que se dirige a los sialoglucanos inmunosupresores.
- En abril de 2022, los investigadores glicoproteómicos de CPTAC desarrollaron " Método de identificación de glucanos con múltiples atributos "Peptide-First".
- En marzo de 2022, investigadores japoneses descubrieron el mecanismo preciso de una enzima asociada al beta-1,2-glucano para proporcionar nueva información sobre el complicado metabolismo del azúcar. Un equipo de investigadores de la Universidad de Niigata y la Universidad de Ciencias de Tokio identificó la estructura y función de una nueva enzima con actividad glicosiltransferasa. Los hallazgos de esta investigación se hicieron públicos el 19 de enero de 2022 y se imprimieron en el Journal of Biological Chemistry, volumen 298, número 3.
- Según un estudio publicado en febrero de 2022 por investigadores de la Universidad del Centro de Glicómica de Copenhague, ahora se puede producir heparina sin utilizar animales mediante estudios de glucómica.
- En febrero de 2022, GlycoMIP, un centro de investigación nacional centrado en la investigación de glicomateriales y dirigido conjuntamente por Virginia Tech y la Universidad de Georgia , celebró la gran inauguración de sus instalaciones para usuarios nacionales con ceremonias de inauguración en ambas universidades. GlycoMIP abordará los obstáculos a nivel nacional en la síntesis de glicomateriales, el modelado informático, la caracterización de materiales y el intercambio de conocimientos a través de investigaciones innovadoras y una instalación nacional única para usuarios que proporcionará herramientas y servicios críticos a la comunidad científica.
Información basada en clases
Según la clase, el mercado de la terapéutica glucómica se divide en aislado y sintético. . En 2021, el segmento sintético representó una mayor cuota de mercado. Sin embargo, se espera que el segmento aislado registre una CAGR mayor del 16,3% durante el período previsto.
Mercado de terapias glicómicas, por clase: 2021 y 2028
Información basada en estructuras
Basado en estructuras, el mercado de terapias glucómicas se segmenta en glicoproteínas, dirigidas al ácido siálico, proteoglicanos, glicosaminoglucanos, glicofosfatidilinositol (GPI) anclado. proteínas y glicanos a base de heparina, dirigidos a glicoesfingolípidos y otros. El segmento de glicoproteínas tuvo la mayor participación de mercado en 2021. Sin embargo, se anticipa que el segmento de ácido siálico objetivo registre la CAGR más alta durante el período de pronóstico.
Información basada en indicaciones
Basado en indicación, el mercado de la terapéutica glucómica se segmenta en trombosis y cáncer. quimioprofilaxis, anemia, antiadhesivos y antiinflamatorio, cataratas, enfermedades de Gaucher, MPS-1 y amp; IV, cáncer, enfermedad de Alzheimer, influenza tipo A & B y otros. La gripe tipo A & El segmento B tuvo la mayor participación de mercado en 2021 y se espera que continúe una tendencia similar durante el período de pronóstico.
Modo de información basada en acciones
Según el modo de acción, el mercado de la terapéutica glucómica se segmenta en inhibe la neuraminidasa; inhibe la heparanasa y las selectinas y bloquea las interacciones entre los factores de crecimiento y el sulfato de heparán; eritropoyetina y terapia de reemplazo enzimático (TRE); activador del plasminógeno tisular; inhibe la glucosilceramida sintasa; interleucina 1, 2 y 3; beta y interferones gamma; y otros. En 2021, la eritropoyetina & El segmento de terapia de reemplazo enzimático (ERT) tenía la mayor participación del mercado. Sin embargo, se espera que el segmento de inhibiciones de la neuraminidasa registre la CAGR más alta durante el período de pronóstico.
Intellihep Ltd; Bioterapéutica Protalix; BioMarin Pharmaceutical Inc.; Corporación Genzyme (Sanofi); Halozyme Therapeutics, Inc.; Bayer AG; Alzheon, Inc.; GlicoMar; GlaxoSmithKline plc.; y F. Hoffmann-La Roche Ltd se encuentran entre los principales actores que operan en el mercado de la terapéutica glucómica. Estas empresas han estado implementando diversas estrategias que han ayudado a su crecimiento, dando como resultado varios desarrollos en el mercado.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The synthetic segment under class segment held the largest market share in 2021.
The glycomic therapeutics market majorly consists of the players such as Intellihep Ltd; Protalix Biotherapeutics; BioMarin Pharmaceutical Inc.; Genzyme Corporation (Sanofi); Halozyme Therapeutics, Inc.; Bayer AG; Alzheon, Inc.; GlycoMar; GlaxoSmithKline plc.; and F. Hoffmann-La Roche Ltd.
Based on geography, the APAC region is anticipated to witness the highest CAGR in glycomic therapeutics market during the forecast period.
The growth of the market is attributed to wide application in various disorders followed by the development of new treatment processes, increasing research and development in the field of glycomic therapeutics, and expanding R&D investments and rising use of glycomics in various diseases leading to development of new treatment processes.
The List of Companies - Glycomic Therapeutics Market
- Intellihep Ltd
- Protalix Biotherapeutics
- BioMarin Pharmaceutical Inc.
- Genzyme Corporation (Sanofi)
- Halozyme Therapeutics, Inc.
- Bayer AG
- Alzheon, Inc.
- GlycoMar
- GlaxoSmithKline plc.
- F. Hoffmann-La Roche Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Aug 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Aug 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Aug 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)